Ophthalmol Glaucoma2022Letter
Re: Beckers et al.: Safety and effectiveness of the PRESERFLO® MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma (2021;doi 10.1016/j.ogla.2021.07.008: Jul 28 [Epub ahead of print].).
No abstract available for this article.
Discussion
Comments and discussion will appear here in a future update.